SPI-1865

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameSPI-1865

Drug Alias Nameamyloid beta peptide 1-42 deposition inhibitor (Satori)gamma-secretase modulators (Satori Pharmaceuticals)SPI-014 (Satori Pharmaceuticals)SPI-1802SPI-1865 +[6]

ClassificationSmall molecules

Mechanisms of ActionGamma-secretase modulatorsBeta amyloid A4 protein aggregation inhibitorsNeuroprotectants

TargetsGamma-secretaseBeta amyloid A4 protein

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSatori Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSatori Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A